(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

MEDROL

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: US

Quick snapshot

MEDROL

ST13

US500000072027547

Class

5, 18

Filing

72027547

Registration

657022

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

Attention: there is active risk

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

18

Latest update

11/19/2017

Classification

Registered

Trademark type

Word

Nice classes

5, 18

Filing date

04/04/1957

Registration date

01/14/1958

Expiration date

-

Recommended action

Perform a full collision analysis and validate classes before any filing or trademark investment.

Next step

These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.

Complete case details

Structured fields from the responsible authority and the official record.

Status date

03/31/2017

Last transaction

11/19/2017

Responsible office

United States Patent and Trademark Office

Status code

800

Official register

Principal Register

First use anywhere

09/18/1956

First use in commerce

09/18/1956

Drawing code

1

Owner type

16

Owner location

Kalamazoo, MI, US

Current location

GENERIC WEB UPDATE

Holders and representatives

Holders

PHARMACIA & UPJOHN COMPANY LLC
PHARMACIA & UPJOHN COMPANY
UPJOHN COMPANY, THE

Representatives

Jania Gorbach Pfizer Inc.

Technical classification

Nice Classes

Class 5Class 18

Vienna Codes

No Vienna codes available.

Goods and services

Class 5

No specification.

Class 18

HORMONAL PREPARATION FOR THE TREATMENT OF RHEUMATOID ARTHRITIS

Publications

History of USPTO decisions and trademark events.

18 publications found

NA89

NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED

03/31/2017

RNL4

REGISTERED AND RENEWED (FOURTH RENEWAL - 10 YRS)

03/31/2017

89AG

REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED

03/31/2017

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

03/31/2017

E89R

TEAS SECTION 8 & 9 RECEIVED

02/06/2017

REM2

COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED

01/14/2017

ASCK

ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY

03/12/2014

CFIT

CASE FILE IN TICRS

01/14/2009

RNL3

REGISTERED AND RENEWED (THIRD RENEWAL - 10 YRS)

08/07/2008

89AG

REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED

08/07/2008

MAIL

PAPER RECEIVED

02/19/2008

PR89

POST REGISTRATION ACTION MAILED - SEC. 8 & 9

09/18/2007

PLGL

ASSIGNED TO PARALEGAL

08/16/2007

89AF

REGISTERED - COMBINED SECTION 8 (10-YR) & SEC. 9 FILED

07/31/2007

E89R

TEAS SECTION 8 & 9 RECEIVED

07/31/2007

RNL2

REGISTERED AND RENEWED (SECOND RENEWAL - 10 YRS)

01/29/1998

9.AF

REGISTERED - SEC. 9 FILED/CHECK RECORD FOR SEC. 8

10/27/1997

REN1

REGISTERED AND RENEWED (FIRST RENEWAL - 20 YRS)

01/14/1978

Continuous trademark protection

Get notified about every new filing that threatens MEDROL or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.